Aprea Therapeutics Inc expected to post a loss of 47 cents a share - Earnings Preview

Aprea Therapeutics

11/08/2021 03:53

* Aprea Therapeutics Inc  APRE.OQ   APRE.O  is expected to show
a no change in quarterly revenue when it reports results on
August 11 (estimated). 
​* Refinitiv's mean analyst estimate for Aprea Therapeutics Inc
is for a loss of 47 cents per share. For the same quarter last
year, the company reported a loss of 78 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 1 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Aprea
Therapeutics Inc is $6​, about 31% above​ its last closing price
of $4.14. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.48       -0.49      -0.46     Beat    6.6
 Dec. 31 2020  -0.67       -0.64      -0.73     Missed  -13.6
 Sep. 30 2020  -0.76       -0.76      -0.58     Beat    23.7​
 Jun. 30 2020  -0.60       -0.60      -0.78     Missed  -29.5
 Mar.          -0.57​      -0.57      -0.45     Beat    20.7​
 31​ 2020​                                              
 Dec. 31 2019              -0.40      -0.64     Missed  -60​
 Sep. 30 2019  -3.95       -3.94      -5.29     Missed  -34.2
 This summary was machine generated August 11 at 02:53 GMT.  All
figures in US dollars unless otherwise stated